Akoustis Technologies Stock Forecast, Price & News

Akoustis Technologies (NASDAQ:AKTS) Frequently Asked Questions

Is Akoustis Technologies a buy right now?

5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Akoustis Technologies in the last year. There are currently 5 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Akoustis Technologies stock.
View analyst ratings for Akoustis Technologies or view top-rated stocks.

How has Akoustis Technologies' stock been impacted by COVID-19?

Akoustis Technologies' stock was trading at $5.31 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, AKTS stock has increased by 29.0% and is now trading at $6.85.
View which stocks have been most impacted by COVID-19.

When is Akoustis Technologies' next earnings date?

Akoustis Technologies is scheduled to release its next quarterly earnings announcement on Monday, February 7th 2022.
View our earnings forecast for Akoustis Technologies.

How were Akoustis Technologies' earnings last quarter?

Akoustis Technologies, Inc. (NASDAQ:AKTS) announced its earnings results on Sunday, October, 31st. The technology company reported ($0.25) EPS for the quarter, missing the Zacks' consensus estimate of ($0.20) by $0.05. The technology company had revenue of $1.87 million for the quarter, compared to analysts' expectations of $1.97 million. Akoustis Technologies had a negative net margin of 573.95% and a negative trailing twelve-month return on equity of 36.49%. Akoustis Technologies's quarterly revenue was up 192.2% compared to the same quarter last year. During the same period in the previous year, the firm earned ($0.23) earnings per share.
View Akoustis Technologies' earnings history.

What guidance has Akoustis Technologies issued on next quarter's earnings?

Akoustis Technologies updated its second quarter 2022 earnings guidance on Monday, November, 8th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $3.50 million-$4 million, compared to the consensus revenue estimate of $3.64 million.

What price target have analysts set for AKTS?

5 analysts have issued 12-month price targets for Akoustis Technologies' shares. Their forecasts range from $13.00 to $20.00. On average, they expect Akoustis Technologies' stock price to reach $16.00 in the next twelve months. This suggests a possible upside of 133.6% from the stock's current price.
View analysts' price targets for Akoustis Technologies or view top-rated stocks among Wall Street analysts.

Who are Akoustis Technologies' key executives?

Akoustis Technologies' management team includes the following people:

• Jeffrey B. Shealy, President, Chief Executive Officer & Director (LinkedIn Profile)
• Robert Dry, Vice President-Operations & Test
• Kenneth Boller, Chief Financial Officer & Controller (LinkedIn Profile)
• David M. Aichele, Executive Vice President-Business Development (LinkedIn Profile)
• Rohan Houlden, Chief Product Officer (LinkedIn Profile)

Who are some of Akoustis Technologies' key competitors?

Some companies that are related to Akoustis Technologies include Plantronics (POLY), AudioCodes (AUDC), ADTRAN (ADTN), Clearfield (CLFD), NETGEAR (NTGR), DZS (DZSI), Exlites Holdings International (EXHI), Sunworks (SUNW), Minim (MINM), SharpLink Gaming (SBET), Franklin Wireless (FKWL), Altigen Communications (ATGN), Zoom Telephonics (ZMTP), Communications Systems (JCS) and ClearOne (CLRO).
View all of AKTS's competitors.

What other stocks do shareholders of Akoustis Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Akoustis Technologies investors own include Inseego (INSG), NVIDIA (NVDA), Square (SQ), Editas Medicine (EDIT), Marvell Technology (MRVL), Alibaba Group (BABA), Invitae (NVTA), Advanced Micro Devices (AMD), CRISPR Therapeutics (CRSP) and JD.com (JD).

What is Akoustis Technologies' stock symbol?

Akoustis Technologies trades on the NASDAQ under the ticker symbol "AKTS."

Who are Akoustis Technologies' major shareholders?

Akoustis Technologies' stock is owned by a number of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (5.32%), Elemental Capital Partners LLC (3.49%), Handelsbanken Fonder AB (2.40%), Granahan Investment Management Inc. MA (1.73%), Geode Capital Management LLC (1.54%) and Penserra Capital Management LLC (1.21%). Company insiders that own Akoustis Technologies stock include Arthur Geiss, David Aichele, Jeffrey B Shealy, Jeffrey B Shealy, Jeffrey Mcmahon, Kenneth Boller, Rohan Houlden, Steven Denbaars and Suzanne B Rudy.
View institutional ownership trends for Akoustis Technologies.

Which institutional investors are selling Akoustis Technologies stock?

AKTS stock was sold by a variety of institutional investors in the last quarter, including Granahan Investment Management Inc. MA, California State Teachers Retirement System, Wolverine Trading LLC, Goldman Sachs Group Inc., New York State Common Retirement Fund, GWM Advisors LLC, Advisor Group Holdings Inc., and Truist Financial Corp. Company insiders that have sold Akoustis Technologies company stock in the last year include Arthur Geiss, David Aichele, Jeffrey B Shealy, Kenneth Boller, Rohan Houlden, Steven Denbaars, and Suzanne B Rudy.
View insider buying and selling activity for Akoustis Technologies or view top insider-selling stocks.

Which institutional investors are buying Akoustis Technologies stock?

AKTS stock was bought by a variety of institutional investors in the last quarter, including Millennium Management LLC, Sargent Investment Group LLC, First Washington CORP, Handelsbanken Fonder AB, Geode Capital Management LLC, Endurance Wealth Management Inc., Morgan Stanley, and UBS Group AG.
View insider buying and selling activity for Akoustis Technologies or or view top insider-buying stocks.

How do I buy shares of Akoustis Technologies?

Shares of AKTS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Akoustis Technologies' stock price today?

One share of AKTS stock can currently be purchased for approximately $6.85.

How much money does Akoustis Technologies make?

Akoustis Technologies has a market capitalization of $356.51 million and generates $6.62 million in revenue each year. The technology company earns $-44.16 million in net income (profit) each year or ($0.97) on an earnings per share basis.

How many employees does Akoustis Technologies have?

Akoustis Technologies employs 99 workers across the globe.

What is Akoustis Technologies' official website?

The official website for Akoustis Technologies is www.akoustis.com.

Where are Akoustis Technologies' headquarters?

Akoustis Technologies is headquartered at 9805 NORTHCROSS CENTER COURT SUITE A, HUNTERSVILLE NC, 28078.

How can I contact Akoustis Technologies?

Akoustis Technologies' mailing address is 9805 NORTHCROSS CENTER COURT SUITE A, HUNTERSVILLE NC, 28078. The technology company can be reached via phone at (704) 997-5735 or via email at [email protected].